Compliance and Regulatory Intelligence - Thought Leadership in transforming Quality Oversight - Risk Management Expert - Systems Thinking - Pharmaceutical Regulatory Science Research - Co-Host of Risk Revolution Podcast
Many challenges in the pharmaceutical manufacturing space arise when important activity, including risk, is outsourced. A 2022 article in Outsourced Pharma shows that outsourcing is a common and essential activity in biopharmaceutical operations. (Credit: @Smita Khanna. BioPlan Associates, Inc.) https://lnkd.in/eRbN-K3Q The image below, from the article, shows the range of activities commonly outsourced. 💡 Ensuring that effective management strategies are in place is critical. This includes processes to manage knowledge about risk. 💡 Why not join PDA Ireland in Cork on the 29th Feb 2024 to discuss these challenges, and more, through the lens of both contract giver & receiver. As it is LEAP DAY - this is a great proposal! https://lnkd.in/eBvghwkf
PDA Ireland
9mo
Thanks for sharing these stats Valerie Mulholland. CMO integration is indeed a huge element of how the biotech industry models their businesses. Our event on the 29 Feb will explore this and you will hear from both contract givers and acceptors on the day.
Senior Executive EHS at Biopharmachem Ireland (Ibec)
9moLooking forward to 29th. See you there Valerie.